Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership5,630 shares
Latest Disclosed Value $ 741,694
Pnc Financial Services Group, Inc. reports 12.24% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 5,630 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $741,694 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 5,016 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 12.24% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,630 614 12.24 742 4.22 0.0001
2026-02-06 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,016 248 5.20 711 6.28 0.0004
2025-11-07 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,768 384 8.76 669 21.42 0.0004
2025-08-08 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,384 992 29.25 551 46.93 0.0004
2025-05-09 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,392 -412 -10.83 375 -27.75 0.0002
2025-02-07 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,804 -224 -5.56 519 11.85 0.0003
2024-11-08 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,028 251 6.65 464 -10.60 0.0003
2024-08-09 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,777 282 8.07 520 7.68 0.0003
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,495 248 7.64 482 12.88 0.0003
2024-03-22 2023-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 3,247 -401 -10.99 428 4.15 0.0003
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,247 -401 428 0.0003
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,648 -66 -1.78 410 17.14 0.0004
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,714 -559 -13.08 350 -18.98 0.0003
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,273 505 13.40 433 -4.00 0.0004
2023-02-10 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,768 -19 -0.50 450 11.66 0.0004
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,787 522 15.99 403 26.33 0.0004
2022-08-12 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,265 115 3.65 319 7.77 0.0003
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,150 684 27.74 296 40.28 0.0003
2022-02-11 2021-12-31 13F NEUROCRINE Common Stock 64125C109 2,466 -1,037 -29.60 211 -36.83 0.0002
2021-11-05 2021-09-30 13F NEUROCRINE Common Stock 64125C109 3,503 10 0.29 334 -2.05 0.0003
2021-08-06 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,493 2,861 452.69 341 450.00 0.0003
2021-05-07 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 632 -23 -3.51 62 -3.12 0.0001
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 655 -117 -15.16 64 -14.67 0.0001
2020-11-06 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 772 113 17.15 75 -6.25 0.0001
2020-08-28 2020-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 659 14 2.17 80 45.45 0.0001
2020-08-07 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 659 14 80 16.6111
2020-05-08 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 645 -14 -2.12 55 -23.61 0.0001
2020-02-07 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 659 -49 -6.92 72 12.50 0.0001
2019-11-08 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 708 -8 -1.12 64 8.47 0.0001
2019-08-09 2019-06-30 13F NEUROCRINE Common Stock 64125C109 716 -309 -30.15 59 -35.16 0.0001
2019-05-10 2019-03-31 13F NEUROCRINE Common Stock 64125C109 1,025 533 108.33 91 160.00 0.0001
2019-02-08 2018-12-31 13F NEUROCRINE Common Stock 64125C109 492 -43 -8.04 35 -47.76 0.0000
2018-11-09 2018-09-30 13F NEUROCRINE Common Stock 64125C109 535 2 0.38 67 28.85 0.0001
2018-08-10 2018-06-30 13F NEUROCRINE Common Stock 64125C109 533 51 10.58 52 33.33 0.0001
2018-05-11 2018-03-31 13F NEUROCRINE Common Stock 64125C109 482 55 12.88 39 21.88 0.0000
2018-02-09 2017-12-31 13F NEUROCRINE Common Stock 64125C109 427 -1,738 -80.28 32 -75.76 0.0000
2017-11-13 2017-09-30 13F NEUROCRINE Common Stock 64125C109 2,165 -4,035 -65.08 132 -53.68 0.0001
2017-08-11 2017-06-30 13F NEUROCRINE 64125C109 6,200 -408 -6.17 285 -0.35 0.0003
2017-05-12 2017-03-31 13F NEUROCRINE Common Stock 64125C109 6,608 -968 -12.78 286 -3.05 0.0003
2017-02-10 2016-12-31 13F NEUROCRINE Common Stock 64125C109 7,576 -13,414 -63.91 295 -72.22 0.0003
2016-11-04 2016-09-30 13F NEUROCRINE Common Stock 64125C109 20,990 -57,099 -73.12 1,062 -70.08 0.0012
2016-08-05 2016-06-30 13F NEUROCRINE Common Stock 64125C109 78,089 6,025 8.36 3,549 24.48 0.0042
2016-05-06 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 72,064 14,044 24.21 2,851 -13.13 0.0033
2016-02-05 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,020 8,578 17.35 3,282 66.85 0.0039
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 49,442 18,660 60.62 1,967 33.81 0.0023
2015-08-05 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,782 21,679 238.15 1,470 307.20 0.0016
2015-05-08 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,103 8,680 2,052.01 361 3,911.11 0.0004
2015-02-06 2014-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 423 200 89.69 9 200.00 0.0000
2015-02-06 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 423 9
2014-11-07 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 223 0 0.00 3 0.00 0.0000
2014-08-08 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 223 0 0.00 3 -25.00 0.0000
2014-05-09 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 223 223 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.